178 related articles for article (PubMed ID: 38131545)
1. Bibliometric and visualized analysis of diabetic macular edema.
Wei J; Shu Y; Wang Y; Liu H
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S66-S74. PubMed ID: 38131545
[TBL] [Abstract][Full Text] [Related]
2. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.
Peng C; Kuang L; Zhao J; Ross AE; Wang Z; Ciolino JB
J Control Release; 2022 May; 345():625-645. PubMed ID: 35321827
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
Ceylan A; Dogan ME; Demircan A; Akar Y
Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
[TBL] [Abstract][Full Text] [Related]
4. Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey.
Yilmaz M; Citirik M; Rahmanlar H; Alkan A; Gursoz H
Rom J Ophthalmol; 2022; 66(4):304-309. PubMed ID: 36589330
[No Abstract] [Full Text] [Related]
5. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
6. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
7. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.
Kaya M; Atas F; Kocak N; Ozturk T; Ayhan Z; Kaynak S
Curr Eye Res; 2023 May; 48(5):498-505. PubMed ID: 36629472
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
Mahapatra SK; Kumari S
Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
[TBL] [Abstract][Full Text] [Related]
10. Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection.
Nawar AE; Wasfy T; Shafik HM
BMC Ophthalmol; 2022 Jun; 22(1):287. PubMed ID: 35768859
[TBL] [Abstract][Full Text] [Related]
11. Bibliometric and visualized analysis of DME from 2012 to 2022.
Liu Y; Zhu Q; Jiang P; Yang Y; Wang M; Liang H; Peng Q; Zhang Q
Medicine (Baltimore); 2024 Mar; 103(13):e37347. PubMed ID: 38552080
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
Mishra SK; Sinha S; Chauhan R; Kumar A
Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
[TBL] [Abstract][Full Text] [Related]
13. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
[TBL] [Abstract][Full Text] [Related]
14. Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
Korobelnik JF; Gaucher D; Baillif S; Creuzot-Garcher C; Kodjikian L; Weber M
Ophthalmologica; 2023; 246(2):71-80. PubMed ID: 36646050
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone intravitreal implants for diabetic macular edema refractory to ranibizumab monotherapy or combination therapy.
Gutiérrez-Benítez L; Millan E; Arias L; Garcia P; Cobos E; Caminal M
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):475-80. PubMed ID: 26008920
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of retinal inflammatory biomarkers after intravitreal steroid implant and Ranibizumab injection in diabetic macular edema.
Muftuoglu IK; Tokuc EO; Sümer F; Karabas VL
Eur J Ophthalmol; 2022 May; 32(3):1627-1635. PubMed ID: 34219488
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study.
Isik P; Sizmaz S; Esen E; Uysal A; Demircan N
Int Ophthalmol; 2023 Nov; 43(11):4171-4180. PubMed ID: 37505290
[TBL] [Abstract][Full Text] [Related]
19. Practical Lessons from Protocol T for the Management of Diabetic Macular Edema.
Mukkamala L; Bhagat N; Zarbin M
Dev Ophthalmol; 2017; 60():109-124. PubMed ID: 28427070
[TBL] [Abstract][Full Text] [Related]
20. Subfoveal choroidal thickness changes after intravitreal ranibizumab injections in different patterns of diabetic macular edema using a deep learning-based auto-segmentation.
Wang XN; Cai X; He S; Zhang X; Wu Q
Int Ophthalmol; 2023 Dec; 43(12):4399-4407. PubMed ID: 33783677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
